Reunion Neuroscience Inc.

NASDAQ: REUN · Real-Time Price · USD
1.12
-0.01 (-0.88%)
At close: Jul 31, 2023, 9:59 PM

Reunion Neuroscience Income Statement

Financials in CAD. Fiscal year is April - March.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
n/a 4.86M 960.89K
Cost of Revenue
n/a 9.15M 1.54M
Gross Profit
n/a -4.29M -583.43K
Operating Income
-20.37M -52.6M -18.98M
Interest Income
691.79K 425.9K 51.04K
Pretax Income
-38.1M -54.69M -23.12M
Net Income
-66.22M -55.79M -23.42M
Selling & General & Admin
12.96M 37.72M 13.69M
Research & Development
12.98M 7.31M 3.42M
Other Expenses
2.02M 3.71M 1.34M
Operating Expenses
27.96M 48.74M 18.45M
Interest Expense
17.73M 1.1M 303.3K
Selling & Marketing Expenses
n/a 3.23M 1.63M
Cost & Expenses
27.96M 57.89M 19.99M
Income Tax Expense
28.12M 1.1M 303.3K
Shares Outstanding (Basic)
11.64M 11.55M 6.61M
Shares Outstanding (Diluted)
11.64M 11.55M 6.61M
EPS (Basic)
-5.69 -4.83 -3.54
EPS (Diluted)
-5.69 -4.83 -3.54
EBITDA
-17.15M -49M -17.58M
EBIT
-20.37M -62.33M -22.81M
Depreciation & Amortization
3.23M 3.6M 1.39M